Schabacker Matthew 4/A

What Happened

• Matthew Schabacker, VP GM Advanced Surgical at CONMED (CNMD), received a grant of 17,471 restricted stock units (RSUs) on 2026-03-02. The filing shows an acquisition of 17,471 derivative shares at $0.00 per share (RSUs are awards, not purchases), with no immediate cash paid or proceeds received.

Key Details

• Transaction type: Award/Grant (code A) — restricted stock units (derivative).
• Date of grant: 2026-03-02; Form 4 amended on 2026-03-18 to correct the amount.
• Price: $0.00 per RSU (typical for RSU awards); reported aggregate value shown as $0.
• Correction note: This Form 4/A increases the originally reported 9,827 RSUs by a special award of 7,644 RSUs for a total of 17,471 RSUs.
• Vesting: RSUs are subject to the Company’s 2025 Long-Term Incentive Plan and generally vest over three years (33% at year 1, 33% at year 2, 34% at year 3).
• Shares owned after transaction: Not specified in this filing.

Context

• These RSUs are a compensation award (not a market purchase or sale). They represent a contingent right to receive one share per RSU upon vesting and do not by themselves indicate buying or selling intent. The amendment was filed to correct the grant quantity, ensuring public records reflect the full 17,471-RSU award.